...
search icon
acxp-img

Acurx Pharmaceuticals LLC, Common Stock

ACXP

NAQ

$0.704

-$0.1

(-12.37%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$12.66M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
668.67K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-1.72
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.68 L
$5 H
$0.704

About Acurx Pharmaceuticals LLC, Common Stock

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameACXPSectorS&P500
1-Week Return-9.18%0.49%-1.93%
1-Month Return-13%-3.1%-3.69%
3-Month Return-61.14%-8.59%0.82%
6-Month Return-63.43%-4.57%3.51%
1-Year Return-82.54%-0.94%21.91%
3-Year Return-81.2%2.88%24.73%
5-Year Return-89.76%35.84%78.4%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses5.93M4.60M12.81M12.09M14.58M[{"date":"2019-12-31","value":40.69,"profit":true},{"date":"2020-12-31","value":31.56,"profit":true},{"date":"2021-12-31","value":87.9,"profit":true},{"date":"2022-12-31","value":82.95,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(5.93M)(4.60M)(12.88M)(12.09M)(14.58M)[{"date":"2019-12-31","value":-593125300,"profit":false},{"date":"2020-12-31","value":-460003800,"profit":false},{"date":"2021-12-31","value":-1288070300,"profit":false},{"date":"2022-12-31","value":-1209400000,"profit":false},{"date":"2023-12-31","value":-1457776800,"profit":false}]
Total Non-Operating Income/Expense-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Pre-Tax Income(5.93M)(4.60M)(12.75M)(12.09M)(14.58M)[{"date":"2019-12-31","value":-593125300,"profit":false},{"date":"2020-12-31","value":-460003800,"profit":false},{"date":"2021-12-31","value":-1274769700,"profit":false},{"date":"2022-12-31","value":-1209277600,"profit":false},{"date":"2023-12-31","value":-1457776800,"profit":false}]
Income Taxes(5.93K)(4.60K)(66.50K)(1.22K)(14.58K)[{"date":"2019-12-31","value":-593425,"profit":false},{"date":"2020-12-31","value":-459804,"profit":false},{"date":"2021-12-31","value":-6650300,"profit":false},{"date":"2022-12-31","value":-122400,"profit":false},{"date":"2023-12-31","value":-1457700,"profit":false}]
Income After Taxes-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(5.93M)(4.60M)(12.75M)(12.09M)(12.72M)[{"date":"2019-12-31","value":-593125300,"profit":false},{"date":"2020-12-31","value":-460003800,"profit":false},{"date":"2021-12-31","value":-1274769700,"profit":false},{"date":"2022-12-31","value":-1209277600,"profit":false},{"date":"2023-12-31","value":-1272368900,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(5.93M)(4.60M)(12.68M)(12.09M)(14.58M)[{"date":"2019-12-31","value":-593125300,"profit":false},{"date":"2020-12-31","value":-460003800,"profit":false},{"date":"2021-12-31","value":-1268119400,"profit":false},{"date":"2022-12-31","value":-1209155200,"profit":false},{"date":"2023-12-31","value":-1457776800,"profit":false}]
EPS (Diluted)-(0.47)(1.48)(1.12)(1.14)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-46.94,"profit":false},{"date":"2021-12-31","value":-148,"profit":false},{"date":"2022-12-31","value":-112,"profit":false},{"date":"2023-12-31","value":-114,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

ACXP
Cash Ratio 0.00
Current Ratio 0.00

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ACXP
ROA (LTM) -132.22%
ROE (LTM) -346.94%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ACXP
Debt Ratio Lower is generally better. Negative is bad. 0.55
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.45

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ACXP
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 4.76
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Acurx Pharmaceuticals LLC share price today?

Acurx Pharmaceuticals LLC (ACXP) share price today is $0.704

Can Indians buy Acurx Pharmaceuticals LLC shares?

Yes, Indians can buy shares of Acurx Pharmaceuticals LLC (ACXP) on Vested. To buy Acurx Pharmaceuticals LLC from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ACXP stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Acurx Pharmaceuticals LLC be purchased?

Yes, you can purchase fractional shares of Acurx Pharmaceuticals LLC (ACXP) via the Vested app. You can start investing in Acurx Pharmaceuticals LLC (ACXP) with a minimum investment of $1.

How to invest in Acurx Pharmaceuticals LLC shares from India?

You can invest in shares of Acurx Pharmaceuticals LLC (ACXP) via Vested in three simple steps:

  • Click on Sign Up or Invest in ACXP stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Acurx Pharmaceuticals LLC shares
What is Acurx Pharmaceuticals LLC 52-week high and low stock price?

The 52-week high price of Acurx Pharmaceuticals LLC (ACXP) is $5. The 52-week low price of Acurx Pharmaceuticals LLC (ACXP) is $0.68.

What is Acurx Pharmaceuticals LLC price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Acurx Pharmaceuticals LLC (ACXP) is

What is Acurx Pharmaceuticals LLC price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Acurx Pharmaceuticals LLC (ACXP) is 4.76

What is Acurx Pharmaceuticals LLC dividend yield?

The dividend yield of Acurx Pharmaceuticals LLC (ACXP) is 0.00%

What is the Market Cap of Acurx Pharmaceuticals LLC?

The market capitalization of Acurx Pharmaceuticals LLC (ACXP) is $12.66M

What is Acurx Pharmaceuticals LLC’s stock symbol?

The stock symbol (or ticker) of Acurx Pharmaceuticals LLC is ACXP

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top